Cargando…
Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses
AIM: To develop a mucosal inactivated vaccines for Newcastle disease (ND) and H9N2 viruses to protect against these viruses at sites of infections through mucosal immunity. MATERIALS AND METHODS: In this study, we prepared two new formulations for mucosal bivalent inactivated vaccine formulations fo...
Autores principales: | Naggar, Heba M. El, Madkour, Mohamed Sayed, Hussein, Hussein Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Veterinary World
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352844/ https://www.ncbi.nlm.nih.gov/pubmed/28344402 http://dx.doi.org/10.14202/vetworld.2017.187-193 |
Ejemplares similares
-
Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus
por: Ali, Zeinab Mohamed, et al.
Publicado: (2017) -
Assessment of in vitro potency of inactivated Newcastle disease oil-adjuvanted vaccines using hemagglutination test and blocking ELISA
por: Aly, Saleh E., et al.
Publicado: (2018) -
Improvements to the live-attenuated Newcastle disease virus vaccine using Carbopol(®) 940 as a stabilizer
por: Abd El-Moneam, Mahmoud Mohamed, et al.
Publicado: (2020) -
Chickens Expressing IFIT5 Ameliorate Clinical Outcome and Pathology of Highly Pathogenic Avian Influenza and Velogenic Newcastle Disease Viruses
por: Rohaim, Mohammed A., et al.
Publicado: (2018) -
Trials for preparation and evaluation of a combined inactivated reassorted H5N1 and Escherichia coli O157 vaccine in poultry
por: Sayed, Marwa Fathy El, et al.
Publicado: (2021)